We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Most cancer tissues showed weak to moderate nuclear and cytoplasmic positivity. Hodgkins lymphoma as well as many cases of prostate and renal cancer were negative.
A majority of malignant cells displayed moderate nuclear and/or cytoplasmic staining. Several malignant lymphomas, lung adenocarcinomas and urothelial cancers were weakly stained or negative.
GENE INFORMATION
Gene name
MBD1 (HGNC Symbol)
Synonyms
CXXC3, PCM1
Description
Methyl-CpG binding domain protein 1 (HGNC Symbol)
Entrez gene summary
The protein encoded by this gene is a member of a family of nuclear proteins related by the presence of a methyl-CpG binding domain (MBD). These proteins are capable of binding specifically to methylated DNA, and some members can also repress transcription from methylated gene promoters. This protein contains multiple domains: MBD at the N-terminus that functions both in binding to methylated DNA and in protein interactions; several CXXC-type zinc finger domains that mediate binding to non-methylated CpG dinucleotides; transcriptional repression domain (TRD) at the C-terminus that is involved in transcription repression and in protein interactions. Numerous alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Feb 2011]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]
Q9UIS9 [Direct mapping] Methyl-CpG-binding domain protein 1
Show all
Predicted intracellular proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0006346 [methylation-dependent chromatin silencing] GO:0006366 [transcription from RNA polymerase II promoter] GO:0008270 [zinc ion binding] GO:0008327 [methyl-CpG binding] GO:0010385 [double-stranded methylated DNA binding] GO:0016363 [nuclear matrix] GO:0016607 [nuclear speck] GO:0045892 [negative regulation of transcription, DNA-templated]